176 related articles for article (PubMed ID: 929130)
1. [Serum digoxin concentration: dependence on body weight and age].
Kaufmann G; Neumann P
Schweiz Med Wochenschr; 1977 Nov; 107(47):1695-9. PubMed ID: 929130
[TBL] [Abstract][Full Text] [Related]
2. [Clinical study on digoxin tablets with high bioavailability (author's transl)].
Flasch CI; Heinz N
Arzneimittelforschung; 1979; 29(6):961-4. PubMed ID: 582792
[TBL] [Abstract][Full Text] [Related]
3. [Digoxin therapy in the aged under serum level control with special reference to hypertension].
Gruber G; Pietruschka WD; Reuschel I; Sorger D; Günther K
Z Gesamte Inn Med; 1980 Jan; 35(1):17-21. PubMed ID: 7405293
[TBL] [Abstract][Full Text] [Related]
4. Endogenous digoxin-like immunoreactivity in elderly patients with normal serum creatinine concentrations.
Lackner TE; Lau BW; Parvin C; Valdes R
Clin Pharm; 1988 Jun; 7(6):449-53. PubMed ID: 3402180
[TBL] [Abstract][Full Text] [Related]
5. [What value do body weight, age and drug anamnesis have as an index of elevated digoxin level?].
Bachmayer K; Wytek R
Wien Klin Wochenschr; 1986 Mar; 98(6):165-70. PubMed ID: 3705594
[TBL] [Abstract][Full Text] [Related]
6. [Radioimmunologic determination of serum digoxin. Methodological and 1st clinical experiences].
Gruber G; Sorger D
Z Gesamte Inn Med; 1979 Jan; 34(2):69-72. PubMed ID: 425583
[TBL] [Abstract][Full Text] [Related]
7. Comparison of methods for estimating digoxin dosing regimens.
Hyneck ML; Johnson MH; Wagner JG; Williams GW
Am J Hosp Pharm; 1981 Jan; 38(1):69-73. PubMed ID: 7211872
[TBL] [Abstract][Full Text] [Related]
8. Clinical studies on digoxin intoxication. I. Serum concentration of digoxin in the elderly and the effect of diuretics.
Suzuki M; Ogawa K
Jpn Heart J; 1980 May; 21(3):341-56. PubMed ID: 7401316
[No Abstract] [Full Text] [Related]
9. Digoxin intoxication: the relationship of clinical presentation to serum digoxin concentration.
Smith TW; Haber E
J Clin Invest; 1970 Dec; 49(12):2377-86. PubMed ID: 5480861
[TBL] [Abstract][Full Text] [Related]
10. NTP Toxicology and Carcinogenesis Studies of 4,4'-Thiobis(6- t -butyl- m -cresol) (CAS No. 96-69-5) in F344/N Rats and B6C3F1 Mice (Feed Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1994 Dec; 435():1-288. PubMed ID: 12595928
[TBL] [Abstract][Full Text] [Related]
11. [Digoxin plasma levels in four different prescription schedules of common use in clinical practice].
Reinbach R; Villa L; Giraudo P; Venegas R; Fernández P
Rev Med Chil; 2003 Apr; 131(4):373-80. PubMed ID: 12870231
[TBL] [Abstract][Full Text] [Related]
12. Serum digoxin level - determined or estimated?
Stĕpán J; Petrásek J; Kölbel F; Havránek T; Babjuk J
Cor Vasa; 1983; 25(1):35-41. PubMed ID: 6342938
[TBL] [Abstract][Full Text] [Related]
13. [The importance of body weight in treatment with digoxin and digoxin derivatives (author's transl)].
Schneider J; Ruiz-Torres A
Dtsch Med Wochenschr; 1977 Jan; 102(4):116-8. PubMed ID: 832590
[TBL] [Abstract][Full Text] [Related]
14. [Serum digoxin in patients on maintenance therapy].
Fallingborg J
Ugeskr Laeger; 1984 Mar; 146(12):879-81. PubMed ID: 6719587
[No Abstract] [Full Text] [Related]
15. Correlation coefficient versus prediction error in assessing the accuracy of digoxin dosing methods.
Lalonde RL; Pao D
Clin Pharm; 1984; 3(2):178-83. PubMed ID: 6723224
[TBL] [Abstract][Full Text] [Related]
16. Serum digoxin concentrations in canine congestive heart failure.
Tobias AH; Bland-van den Berg P; Kruse MM; Tubbesing UH; Berry WL
J S Afr Vet Assoc; 1989 Mar; 60(1):11-4. PubMed ID: 2724277
[TBL] [Abstract][Full Text] [Related]
17. [Blood digoxin and treatment of heart failure in aged patients].
Jouannot P; Lavabre J; Thomas M; Hatt PY
Arch Mal Coeur Vaiss; 1976 Oct; 69(10):1013-21. PubMed ID: 827994
[TBL] [Abstract][Full Text] [Related]
18. Cross-sectional study of heart failure therapy with angiotensin converting enzyme inhibitors and digoxin.
Mahmood SA; Hussein GM; Hamza EA
Saudi Med J; 2004 Aug; 25(8):1060-5. PubMed ID: 15322598
[TBL] [Abstract][Full Text] [Related]
19. Is the volume of distribution of digoxin reduced in patients with renal dysfunction? Determining digoxin pharmacokinetics by fluorescence polarization immunoassay.
Cheng JW; Charland SL; Shaw LM; Kobrin S; Goldfarb S; Stanek EJ; Spinler SA
Pharmacotherapy; 1997; 17(3):584-90. PubMed ID: 9165563
[TBL] [Abstract][Full Text] [Related]
20. Interference of digoxin-like immunoreactive substances with three digoxin immunoassays in patients with various degrees of renal function.
Pleasants RA; Gadsden RH; McCormack JP; Piveral K; Sawyer WT
Clin Pharm; 1986 Oct; 5(10):810-6. PubMed ID: 3780148
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
